Carregant...
Current status of doublet combinations of platinum and fluoropyrimidines using oxaliplatin for advanced gastric cancer
The most common treatment for advanced gastric cancer (AGC) is systemic chemotherapy. The standard treatment for advanced gastric cancer differs worldwide. In Japan, two phase III clinical trials demonstrated the non-inferiority of S-1 compared with 5-fluorouracil (5-FU) and superiority of cisplatin...
Guardat en:
| Publicat a: | Glob Health Med |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
National Center for Global Health and Medicine
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7936367/ https://ncbi.nlm.nih.gov/pubmed/33688593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.35772/ghm.2020.01075 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|